Christie Ojiaku | TGF-β1 Mediates HASM Cell Hyporesponsiveness to β2-Agonist-Induced Relaxation
Recent Posts
- For Cancer Patients, Oncologists Often Have the Final Word.
- Rutgers Startup Seeks to Tap the Power of AI to Become the First Commercial “Self-Driving Lab”.
- The 10 Popular Health Trends You Shouldn’t Try in 2025.
- New NJACTS Publication
- Tech Can Help People Living with Dementia to Help Themselves, NJIT Expert Says.
Categories
- News (2,440)
- Publication (1)